Skip to content
1 min left
0% read
Tiger Global Management logo

Tiger Global Management

Investment Firm
Founded 2001

Tiger Global, a leading investment firm, offers unparalleled global investment opportunities

Share:

Tiger Global Management is an American investment firm that offers unparalleled global investment opportunities. It mainly invests in the software, internet, consumer, and financial technology sectors.

Company Details

  • Founder: Chase Coleman
  • Founded: March 2001
  • Headquarters: New York, United States

Key Features

Focuses on investing in private high-growth companies and also publicly traded companies with strong growth potential.

Provides long-term success to businesses rather than short-term gains by maintaining a good relationship with companies.

The firm is well-recognized for its fast decision-making processes, allowing it to seal deals in highly competitive environments.

Provides follow-on funding for companies in its portfolio to maintain continuity.

Frequently Asked Questions About Tiger Global Management

Tiger Global Management is a finance company. Tiger Global, a leading investment firm, offers unparalleled global investment opportunities

Tiger Global, a leading investment firm, offers unparalleled global investment opportunities.

Tiger Global Management has been operating since 2001. You can verify their legitimacy through their official website and social media presence.

Tiger Global Management operates in the finance sector of the cryptocurrency industry. Compare Tiger Global Management with other finance companies on Crypto News Navigator to evaluate services, features, and reputation before making your decision.

Before using Tiger Global Management, research their track record (operating since 2001), verify their regulatory compliance, read user reviews, and understand their fee structure. Never share your private keys with any service, and start with small amounts until you are comfortable with the platform.

Safety depends on multiple factors including regulatory compliance, security practices, and track record. Tiger Global Management has been operating since 2001. Always enable two-factor authentication, use strong passwords, and never store large amounts on any third-party platform.

Tiger Global Management was founded in 2001.

Tiger Global Management operates on the ["Tron"] blockchain.

Tiger Global Management Details

Tiger Global Management Tags

Latest from Academy

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

Blast Ecosystem Grew 400% in Six Months and Nobody Talked About It

The Blast ecosystem has been crypto's most misunderstood narrative of 2026. While the market fixated on a 98.3% drawdown from all-time highs, less-publicized on-chain data tells a counterintuitive story. Three major protocol upgrades shipped since January 2025, 10% TVL growth appeared week-on-week in April, and 279,520 holders remain HODLing their positions on a chain the world has given up on.

7m
 Why Tokenlon's Revenue Doesn't Match Its Token Price

Why Tokenlon's Revenue Doesn't Match Its Token Price

DEX aggregation is "solved" in DeFi, right? 1inch, Jupiter, Paraswap have you covered. Except the data paints a different picture. Tokenlon quietly processes over $120 million in weekly trading volume and a 99.71% order success rate, yet remains shockingly absent from discussion in industry forums and panels. Either the market is correct and Tokenlon's fundamentals are not what we perceive, or a highly-traveled protocol has been willfully ignored.

Mia Halland logoMia HallandApr 26, 2026
8m
Sixty-Five Million in BioDAOs, BIO at One Cent

Sixty-Five Million in BioDAOs, BIO at One Cent

Bio Protocol's CEO recently revealed that PeptAI designed a new ADHD peptide candidate in 24 hours for roughly $1,500 in initial lab validation. While crypto traders focus on memecoins, Bio Protocol has quietly built a scientific funding platform backed by Pfizer Ventures, Binance Labs, and Arthur Hayes' Maelstrom Fund. The bio price trades at $0.031, down 96.5% from its all-time high of $0.889, despite $65M in combined BioDAO research funding and active clinical trials.

8m